FDA: Popular Retailer Recalls Cheese Over Contamination Concerns
It was made a Class II recall, which means consuming the product may cause serious adverse health concerns.
Below is more information about the recalled product.
Processed cheese can last a good bit of time in the fridge, which is why it's worth checking the back of yours for recently recalled Happy Farms by Aldi Colby Jack Finely Shredded Cheese. The product was recalled in February over potential foreign material contamination. Now, the U.S. Food and Drug Administration (FDA) is classifying it as a Class II recall, meaning that consumption could cause 'serious adverse health consequences.'
Four-hundred cases of the 12-ounce pouches of cheese were recalled in four states—Connecticut, Michigan, Ohio, and Pennsylvania—because they could potentially be contaminated with foreign matter—specifically, stainless steel fragments. The packages have the item number of 170374, the UPC code 4061463330840, and best-by dates of July 13, 2025 and July 14, 2025. If you believe you have affected product, do not eat it.
A press release announcing the recall was not published, so further details regarding how the cheese was contaminated are not available, nor are specific disposal or return instructions. However, according to Aldi's recall policy, the stores work to 'swiftly and effectively remove such products' from shelves. 'A 'pull-from-sale' alert from either the manufacturer of the suspect product or our own Corporate Buying Department will trigger a rapid response plan for handling recalls,' the grocer's site reads. 'Products that do not meet Aldi or government standards in any of these areas will be efficiently and effectively removed from sale.'
If you do still happen to have recalled product, reschedule taco night and follow the standard procedure for disposal and reaching out to either the store you purchased it from or the manufacturer, which, in this case, is Great Lakes Cheese Co Inc. The manufacturer can be reached at 440-834-2500 or via email at hello@greatlakescheese.com.
Other wellness and food products recently impacted by recalls include acne treatments, canned tuna, pancake mix, and more. A February report published by the Public Interest Research Group, a nonprofit consumer protection group, analyzed data from food recalls in 2024 and found that there were about 300 food recalls last year leading to nearly 1,400 illnesses associated with pathogens like salmonella, E. coli, and others.
Food safety experts attribute the apparent rise in numbers to a few causes, including a lack of proper sanitation practices and increased monitoring and reporting of these issues overall. 'We don't find outbreaks if we don't look for them,' Barbara Kowalcyk, Ph.D., associate professor and director of the Institute for Food Safety and Nutrition Security at George Washington University previously told Prevention. 'We're doing more investigations, but we also have better tools to do investigations with.' As a result, the U.S. may be experiencing more outbreaks and recalls than before, but the food supply is becoming more tightly regulated, she said.
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
You're Ruining Your Gains If You Skip These 8 Recovery Foods
You're Ruining Your Gains If You Skip These 8 Recovery Foods originally appeared on Men's Fitness. Men's Fitness aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. After an intense workout, the body needs to repair damaged muscle tissue. Pick the right food and you can jump-start that recovery process without ruining the gains you made in the gym. Amino acids—the building blocks of protein—are essential to bolstering recovery. And to ensure you get adequate amino acids, you need to eat protein. Your body also needs glycogen, found in carb-rich foods, since stores gets depleted during training. Eating a combo of protein and carbs is key to workout recovery, and foods that are good sources of both should become staples in your diet. Add these eight healthy eats to your diet to maximize recovery after a workout. Best Post-Workout Recovery Foods Lean Meat Although our bodies produce non-essential amino acids, we also need essential amino acids, ones that are not made in the body and must be consumed from our diets. One of the best sources of essential amino acids is lean meat such as chicken, turkey, and ground beef. According to the FDA, a 'lean' meat contains less than 10 grams of fat, 4.5 grams or less of saturated fat, and less than 95 milligrams of cholesterol per 100 grams. Choose meats that are at least 90 percent lean to ensure you're not getting too much saturated fat and cholesterol. Quinoa One cup of cooked quinoa contains about 8 grams of protein and 40 grams of carbohydrates, making it a nutrient-packed post-workout dish. Unlike other grains, quinoa is a complete protein since it contains all nine essential amino acids, which results in better muscle recovery and more energy. Plain Greek Yogurt Greek yogurt has 15 to 20 grams of protein per 6 ounces compared to 9 grams of protein in an identical serving of regular yogurt. The protein in Greek yogurt is predominantly casein, which digests slower than whey and boasts a full essential amino acid profile. Opt for plain Greek yogurt since it has substantially less sugar than flavored Greek yogurt. To really capitalize on the benefits of casein, eat it before bedtime for extended amino acid digestion. Smoothies Smoothies make a great post-workout recovery drink because of the instant absorption of a custom assortment of nutrients. Just be mindful of how much sugar you add—piling on the fruit can quickly turn a post-workout "nutrition shake" into a secret sugar bomb. Bananas Nature designed the humble banana to be a post-workout recovery machine. One serving includes about 27 grams of carbohydrates, an essential energy resource to ignite your body's muscle repair systems. Additionally, a potassium-packed banana replenishes the depleted electrolyte stores in your muscles, reducing soreness and speeding up the recovery process. The best part is that bananas are naturally sweet, which means it's an ideal addition to a post-workout protein shake or smoothie without adding any refined sugar. Low-fat Chocolate Milk The perfect recovery ratio of carbohydrates to protein is 4:1, according to a growing collection of studies. Chocolate milk matches this ratio better than any sugary sports drink, turning the lunch box staple into a powerful recovery option. A study from Applied Physiology, Nutrition, and Metabolism also found exercisers are able to retain more than twice the amount of fluid in chocolate milk than in a sports drink after a workout, meaning the body is able to absorb more protein with less volume. Avocados Bananas get all the attention when it comes to potassium, but avocados actually have an average of 35 percent more per serving. The fruit is also full of monosaturated fats, which have been linked to reducing cholesterol levels. With an additional 3 grams of protein, vital for muscle growth, the avocado is a filling addition to a post-workout meal. Sweet Potatoes Another potassium powerhouse, the sweet potato contains 448 milligrams in one serving. Because of its orange hue it also comes packed with carotenoids—compounds that aid cell repair, which is vital during the recovery process after a workout. The starchy carbs from sweet potatoes also help restock energy stores, while the fiber will keep you full and encourage you not to spring for something less healthy later in the Ruining Your Gains If You Skip These 8 Recovery Foods first appeared on Men's Fitness on Aug 1, 2025 This story was originally reported by Men's Fitness on Aug 1, 2025, where it first appeared. Solve the daily Crossword
Buzz Feed
4 hours ago
- Buzz Feed
Never Do This In Public Restrooms, Says Germ Expert
Using a public restroom is rarely a joyous occasion. They're filled with sights and smells that can strike fear in the hardest of hearts (and stomachs), and still, most of us have to venture into them at some point if we ever want to live a life outside of our homes. So how can we make our time in a public bathroom better or safer or, at the very least, less gross? That's we ― Raj Punjabi and Noah Michelson, hosts of HuffPost's Am I Doing It Wrong? podcast ― asked microbiologist Jason Tetro, aka 'The Germ Guy,' to school us on when he dropped by our studio. 'Every time I talk about toilet seats and toilets, I'm always saying, 'Well, it's not germy — everything is germier than a toilet seat,'' Tetro told us. '[I'm basing that on] studies that were done back in the 1970s and controlled laboratory environments that were mimicking the home... [but those toilets] also had a lid.' That lid, which is absent from the vast majority of toilets in public restrooms, is key, he said, to containing what scientists call a 'poo plume,' the droplets and aerosol particles that can spray up to six feet out of the toilet when we flush. 'As a result of [there not being a lid], there's that plume that comes from the toilet that ends up on the seat, and no matter where you go, you're always going to find that about 50% of the [public restroom] toilet seats at any given time are going to have some kind of poo germs on them in the range of hundreds [of particles],' he said. Those poo particles can contain E. coli, salmonella, or even norovirus, all of which, if present in high enough concentrations, can make us sick — but not from sitting on the toilet seat. 'We do see potentially some low level of all sorts of different types of bacteria and viruses that could potentially cause an infection, but the reality is, unless you have a cut, then there's really no opportunity for that to get into your skin to cause a problem,' Tetro, the author of The Germ Files and The Germ Code, explained. However, droplets in the air are a different matter altogether. That's why he says we should flush the toilet before using it to 'get a fresh' bowl and never stay in the stall after flushing. 'Make sure that you kind of get out of the stall for 30 seconds to let whatever was aerosol or the droplets to fall and then you can go back in,' he said, noting that he actually does this himself. 'So here's the problem: If it's norovirus or some of the more really troublesome bacteria like 0157:H7, then you may actually end up getting exposed to a high enough level that it could potentially cause infection,' he warned. That's because the droplets from the plume could land in your mouth or nose — which is even more of a danger if you're standing in close proximity to a public restroom toilet that features an extremely powerful flusher. 'So if you're gonna go for the clean or for the fresh bowl, make sure that your face is nowhere near that plume,' he added. Once you've finished your business, don't stick around in the stall after you've flushed either — unless you want to be showered by a plume of your own poo particles. We also chatted with Tetro about the germiest part of a public restroom (spoiler: it's not the toilet seat), what to do if there's no soap in the bathroom, and much more. Listen to the full episode above or wherever you get your podcasts.
Yahoo
5 hours ago
- Yahoo
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032
SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial of IBI3032, the company's novel oral GLP-1R agonist. IBI3032 is an orally administered small-molecule GLP-1 receptor agonist with bias for cAMP signaling pathway, discovered and developed by Innovent Biologics with proprietary rights. Preclinical data demonstrate its superior pharmacokinetic (PK) and physicochemical properties compared to peer compounds. In animal models, IBI3032 achieved 5 to 10 times higher oral exposure at equivalent doses, with improved efficacy and good tolerability in both GLP-1R KI DIO mice and obese monkey models, achieving comparable therapeutic effects at lower doses. The Phase 1 clinical trials of IBI3032 are planned to be conducted concurrently in China and the U.S. Dosing in healthy volunteers and overweight or obese participants is expected to begin in the second half of 2025. Innovent is building up its CVM pipeline with mazdutide as the cornerstone, and the initiation of the IBI3032 clinical study marks a significant step in the evolution of its CVM pipeline portfolio with global potential. Dr. Lei Qian, Chief R&D Officer for General Biomedicines Pipeline at Innovent Biologics, said, "GLP-1 has emerged as a blockbuster target over the past decade. Its oral form, with its convenience, flexibility, and unique advantage in combination treatment strategies, holds promise as a differentiated complement to GLP-1R-targeting biologicals. Beyond traditional applications in diabetes and weight management, oral GLP-1 possess potential in treating related diseases such as hypertension and OSA (obstructive sleep apnea). IBI3032 has demonstrated its promising efficacy profiles in animal models, where IBI3032 exhibited a longer elimination half-life and higher drug exposure levels than its competitors at the same dose. We are excited to advance this candidate into clinical development. This IND approval reflects Innovent's strong R&D capabilities and, most importantly, our commitment to global innovation. We hope that in the near future, IBI3032 can offer more effective and convenient treatment options to benefit patients around the world. " About IBI3032 IBI3032 is a novel oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1RA). By efficiently and selectively targeting GLP-1R, it activates downstream signal transduction, thereby delaying gastric emptying, inhibiting appetite, and promoting insulin secretion, and ultimately supporting the treatment of insulin-related metabolic diseases such as obesity and T2DB. Discovered through a structure-based drug design (SBDD) strategy combined with systematic physicochemical property optimization, IBI3032 has shown better PK and physicochemical properties compared to similar compounds. The IND application of IBI3032 was accepted by China's National Medical Products Administration (NMPA) and approved by the U.S. Food and Drug Administration (FDA). A multi-regional Phase 1 clinical study of IBI3032 is planned for initiation in the second half of 2025. About Innovent Biologics Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 16 products in the market. It has 2 new drug applications under regulatory review, 4 assets in Phase III or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit or follow Innovent on Facebook and LinkedIn. Statement: （1）Innovent does not recommend the use of any unapproved drug (s)/indication (s). （2）Ramucirumab (Cyramza)，Selpercatinib (Retsevmo) and Jaypirca (pirtobrutinib) were developed by Eli Lilly and Company. Forward-Looking Statements This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Innovent Biologics, Inc. ("Innovent" or "Company"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly. These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company's competitive environment and political, economic, legal and social conditions. The Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect. View original content: SOURCE Innovent Biologics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
